$0.280
-0.017 (-6.23%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
HRTX Prediction & Forecast by Similar Chart Analysis
Alphio's HRTX stock price prediction model matches the current Heron Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.29 (-0.65%). The 1-week path is $0.27 (-8.61%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Heron Therapeutics Inc Stock?
Heron Therapeutics Inc is not a good buy right now due to significant financial losses and a low current price of $0.2951, which is near its 52-week low of $0.26. The company reported a net loss of $5.49 million in Q2 2026, and its forward P/E ratio is high at 46.95, indicating that the stock may be overvalued at this time. Additionally, the RSI is at 39.15, suggesting the stock is nearing oversold territory but not yet a strong buy signal. The main risk is the ongoing litigation regarding its CINVANTI patents, which has already led to a significant drop in stock price and could continue to impact future performance.
HRTX stock price ended at $0.28 on Thursday, after losing -6.23%
Heron Therapeutics Inc (HRTX) last closed at $0.293, gaining +4.64%. These facts feed the 1-day and 1-week HRTX price prediction above.
Analyst Consensus
Heron Therapeutics Inc (HRTX): 11 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Heron Therapeutics Inc (HRTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches HRTX, ranked by similarity.
Seasonality analysis for HRTX
Historically the probability of a positive November return for HRTX is 0.00%. February offers the highest probability of a positive month at 75.86%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for HRTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $2.29 | $2.32 | $2.43 | +691.77% |
| Dec 2026 | $1.66 | $1.91 | $2.09 | +551.82% |
In 2026, Heron Therapeutics Inc (HRTX) is projected to range from $1.66 to $2.43.
Heron Therapeutics Inc 2026 monthly forecast
In Nov 2026, Heron Therapeutics Inc is projected to average $2.32, with a low of $2.29 and high of $2.43.
In Dec 2026, Heron Therapeutics Inc is projected to average $1.91, with a low of $1.66 and high of $2.09.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.